Kramer CM, Borlaug BA, Zile MR, Ruff D, DiMaria JM, Menon V, Ou Y, Zarante AM, Hurt KC, Murakami M, Packer M, SUMMIT Trial Study Group
But as with any compound, especially one not yet clinically approved for human use , its safety depends on: The quality of the peptide The accuracy of the dose and administration The duration and purpose of your use Your individual health profile and risk tolerance While BPC-157 exhibits an extraordinary safety profile in animals, its long-term safety in humans remains to be fully established. Sikiric, P
Clinical symptoms of ergotism in animals include gangrene, abortion, convulsions, suppression of lactation and hypersensitivity [150]
At Hastings Law Firm, were closely monitoring these developments, bringing our extensive experience in medical malpractice and pharmaceutical injury cases to bear on this emerging issue
If you are interested in weight loss support you can start a consultation here